295 related articles for article (PubMed ID: 30405689)
21. Deep Learning-Based Multi-Omics Integration Robustly Predicts Relapse in Prostate Cancer.
Wei Z; Han D; Zhang C; Wang S; Liu J; Chao F; Song Z; Chen G
Front Oncol; 2022; 12():893424. PubMed ID: 35814412
[TBL] [Abstract][Full Text] [Related]
22. PathME: pathway based multi-modal sparse autoencoders for clustering of patient-level multi-omics data.
Lemsara A; Ouadfel S; Fröhlich H
BMC Bioinformatics; 2020 Apr; 21(1):146. PubMed ID: 32299344
[TBL] [Abstract][Full Text] [Related]
23. DeepAutoGlioma: a deep learning autoencoder-based multi-omics data integration and classification tools for glioma subtyping.
Munquad S; Das AB
BioData Min; 2023 Nov; 16(1):32. PubMed ID: 37968655
[TBL] [Abstract][Full Text] [Related]
24. Performance Comparison of Deep Learning Autoencoders for Cancer Subtype Detection Using Multi-Omics Data.
Franco EF; Rana P; Cruz A; Calderón VV; Azevedo V; Ramos RTJ; Ghosh P
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33921978
[TBL] [Abstract][Full Text] [Related]
25. Network-based integration of multi-omics data for clinical outcome prediction in neuroblastoma.
Wang C; Lue W; Kaalia R; Kumar P; Rajapakse JC
Sci Rep; 2022 Sep; 12(1):15425. PubMed ID: 36104347
[TBL] [Abstract][Full Text] [Related]
26. Integrating multi-omics data through deep learning for accurate cancer prognosis prediction.
Chai H; Zhou X; Zhang Z; Rao J; Zhao H; Yang Y
Comput Biol Med; 2021 Jul; 134():104481. PubMed ID: 33989895
[TBL] [Abstract][Full Text] [Related]
27. Predicting clinical outcomes in neuroblastoma with genomic data integration.
Baali I; Acar DAE; Aderinwale TW; HafezQorani S; Kazan H
Biol Direct; 2018 Sep; 13(1):20. PubMed ID: 30621745
[TBL] [Abstract][Full Text] [Related]
28. MultiGATAE: A Novel Cancer Subtype Identification Method Based on Multi-Omics and Attention Mechanism.
Zhang G; Peng Z; Yan C; Wang J; Luo J; Luo H
Front Genet; 2022; 13():855629. PubMed ID: 35391797
[TBL] [Abstract][Full Text] [Related]
29. Survival stratification for colorectal cancer via multi-omics integration using an autoencoder-based model.
Song H; Ruan C; Xu Y; Xu T; Fan R; Jiang T; Cao M; Song J
Exp Biol Med (Maywood); 2022 Jun; 247(11):898-909. PubMed ID: 34904882
[TBL] [Abstract][Full Text] [Related]
30. An integrative deep learning framework for classifying molecular subtypes of breast cancer.
Mohaiminul Islam M; Huang S; Ajwad R; Chi C; Wang Y; Hu P
Comput Struct Biotechnol J; 2020; 18():2185-2199. PubMed ID: 32952934
[TBL] [Abstract][Full Text] [Related]
31. Distillation of the clinical algorithm improves prognosis by multi-task deep learning in high-risk Neuroblastoma.
Maggio V; Chierici M; Jurman G; Furlanello C
PLoS One; 2018; 13(12):e0208924. PubMed ID: 30532223
[TBL] [Abstract][Full Text] [Related]
32. Unsupervised classification of multi-omics data during cardiac remodeling using deep learning.
Chung NC; Mirza B; Choi H; Wang J; Wang D; Ping P; Wang W
Methods; 2019 Aug; 166():66-73. PubMed ID: 30853547
[TBL] [Abstract][Full Text] [Related]
33. Accumulation of potential driver genes with genomic alterations predicts survival of high-risk neuroblastoma patients.
Suo C; Deng W; Vu TN; Li M; Shi L; Pawitan Y
Biol Direct; 2018 Jul; 13(1):14. PubMed ID: 30012197
[TBL] [Abstract][Full Text] [Related]
34. Deep latent space fusion for adaptive representation of heterogeneous multi-omics data.
Zhang C; Chen Y; Zeng T; Zhang C; Chen L
Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35079777
[TBL] [Abstract][Full Text] [Related]
35. Integration strategies of multi-omics data for machine learning analysis.
Picard M; Scott-Boyer MP; Bodein A; Périn O; Droit A
Comput Struct Biotechnol J; 2021; 19():3735-3746. PubMed ID: 34285775
[TBL] [Abstract][Full Text] [Related]
36. Robust deep learning model for prognostic stratification of pancreatic ductal adenocarcinoma patients.
Ju J; Wismans LV; Mustafa DAM; Reinders MJT; van Eijck CHJ; Stubbs AP; Li Y
iScience; 2021 Dec; 24(12):103415. PubMed ID: 34901786
[TBL] [Abstract][Full Text] [Related]
37. Chromosome band 11q23 deletion predicts poor prognosis in bone marrow metastatic neuroblastoma patients without MYCN amplification.
Yue ZX; Xing TY; Gao C; Liu SG; Zhao W; Zhao Q; Wang XS; Jin M; Ma XL
Cancer Commun (Lond); 2019 Nov; 39(1):68. PubMed ID: 31685009
[TBL] [Abstract][Full Text] [Related]
38. Deep learning-based model for predicting progression in patients with head and neck squamous cell carcinoma.
Zhao Z; Li Y; Wu Y; Chen R
Cancer Biomark; 2020; 27(1):19-28. PubMed ID: 31658045
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic classification of cancers using extreme gradient boosting algorithm and multi-omics data.
Ma B; Meng F; Yan G; Yan H; Chai B; Song F
Comput Biol Med; 2020 Jun; 121():103761. PubMed ID: 32339094
[TBL] [Abstract][Full Text] [Related]
40. Predicting Neuroblastoma Patient Risk Groups, Outcomes, and Treatment Response Using Machine Learning Methods: A Review.
Jahangiri L
Med Sci (Basel); 2024 Jan; 12(1):. PubMed ID: 38249081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
